BG64053B1 - Производни на 5-арил-3-(8-азабицикло(3.2.1)окт-3-ил)- 1,3,4-оксадиазол-2(3н)-он като лиганди на 5-нт долу 4 рецептори - Google Patents

Производни на 5-арил-3-(8-азабицикло(3.2.1)окт-3-ил)- 1,3,4-оксадиазол-2(3н)-он като лиганди на 5-нт долу 4 рецептори Download PDF

Info

Publication number
BG64053B1
BG64053B1 BG103810A BG10381099A BG64053B1 BG 64053 B1 BG64053 B1 BG 64053B1 BG 103810 A BG103810 A BG 103810A BG 10381099 A BG10381099 A BG 10381099A BG 64053 B1 BG64053 B1 BG 64053B1
Authority
BG
Bulgaria
Prior art keywords
group
general formula
compound
azabicyclo
mixture
Prior art date
Application number
BG103810A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103810A (en
Inventor
Samir Jegham
Alistair Lochead
Frederic Galli
Alain Nedelec
Axelle Samson
Thierry Gallet
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of BG103810A publication Critical patent/BG103810A/xx
Publication of BG64053B1 publication Critical patent/BG64053B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG103810A 1997-04-18 1999-10-15 Производни на 5-арил-3-(8-азабицикло(3.2.1)окт-3-ил)- 1,3,4-оксадиазол-2(3н)-он като лиганди на 5-нт долу 4 рецептори BG64053B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9704802A FR2762316B1 (fr) 1997-04-18 1997-04-18 Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
PCT/FR1998/000754 WO1998047898A1 (fr) 1997-04-18 1998-04-15 Derives de 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one en tant que ligands des recepteurs 5-ht4

Publications (2)

Publication Number Publication Date
BG103810A BG103810A (en) 2000-06-30
BG64053B1 true BG64053B1 (bg) 2003-11-28

Family

ID=9506076

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103810A BG64053B1 (bg) 1997-04-18 1999-10-15 Производни на 5-арил-3-(8-азабицикло(3.2.1)окт-3-ил)- 1,3,4-оксадиазол-2(3н)-он като лиганди на 5-нт долу 4 рецептори

Country Status (32)

Country Link
US (1) US6255319B1 (sk)
EP (1) EP0975631B1 (sk)
JP (1) JP2001521542A (sk)
KR (1) KR20010006452A (sk)
CN (1) CN1260794A (sk)
AR (1) AR012458A1 (sk)
AT (1) ATE206424T1 (sk)
AU (1) AU742666B2 (sk)
BG (1) BG64053B1 (sk)
BR (1) BR9808926A (sk)
CA (1) CA2286106A1 (sk)
CO (1) CO4750656A1 (sk)
CZ (1) CZ289154B6 (sk)
DE (1) DE69801905T2 (sk)
DK (1) DK0975631T3 (sk)
EE (1) EE03769B1 (sk)
ES (1) ES2165162T3 (sk)
FR (1) FR2762316B1 (sk)
HU (1) HUP0002456A3 (sk)
IL (1) IL132352A0 (sk)
NO (1) NO995040L (sk)
NZ (1) NZ500396A (sk)
PL (1) PL186894B1 (sk)
PT (1) PT975631E (sk)
RU (1) RU2186066C2 (sk)
SI (1) SI0975631T1 (sk)
SK (1) SK283441B6 (sk)
TR (1) TR199902600T2 (sk)
TW (1) TW502005B (sk)
UA (1) UA57071C2 (sk)
WO (1) WO1998047898A1 (sk)
ZA (1) ZA983257B (sk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0211230D0 (en) * 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
AU2004226452B2 (en) * 2003-03-26 2008-07-24 Merck Sharp & Dohme Corp. Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
JP2007511559A (ja) * 2003-11-18 2007-05-10 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 固形医薬製剤
WO2005123718A2 (en) 2004-06-15 2005-12-29 Pfizer Japan Inc. Benzimidazolone carboxylic acid derivatives
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
SE532388C2 (sv) * 2008-03-14 2010-01-12 Tetra Laval Holdings & Finance Förpackningslaminat och -behållare med två separata gasbarriärskikt samt metod för deras framställning
JP6348568B2 (ja) * 2013-03-15 2018-06-27 モンサント テクノロジー エルエルシー 線虫害虫防除のためのｎ−，ｃ−二置換アゾール
GB201814151D0 (en) * 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2135414T3 (es) * 1991-09-12 1999-11-01 Smithkline Beecham Plc Antagonistas del receptor 5-ht4.
DE69319939T2 (de) * 1992-02-04 1999-02-18 Eisai Co., Ltd., Tokio/Tokyo Aminobenzoesäure Derivate
AU667874B2 (en) * 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
SK282335B6 (sk) * 1995-11-09 2002-01-07 Sanofi-Synthelabo Deriváty 5-fenyl-3-(piperidin-4-yl)-1,3,4,-oxadiazol-2(3H)-ónu, spôsob ich prípravy a farmaceutický prostriedok, ktorý ich obsahuje

Also Published As

Publication number Publication date
SI0975631T1 (en) 2002-06-30
DE69801905D1 (de) 2001-11-08
EP0975631B1 (fr) 2001-10-04
PT975631E (pt) 2002-03-28
DK0975631T3 (da) 2002-01-28
AU742666B2 (en) 2002-01-10
CN1260794A (zh) 2000-07-19
JP2001521542A (ja) 2001-11-06
DE69801905T2 (de) 2002-07-04
FR2762316A1 (fr) 1998-10-23
BG103810A (en) 2000-06-30
ES2165162T3 (es) 2002-03-01
CZ289154B6 (cs) 2001-11-14
CZ364199A3 (cs) 2000-03-15
NO995040D0 (no) 1999-10-15
KR20010006452A (ko) 2001-01-26
UA57071C2 (uk) 2003-06-16
ZA983257B (en) 1998-10-19
BR9808926A (pt) 2000-08-01
EP0975631A1 (fr) 2000-02-02
AR012458A1 (es) 2000-10-18
ATE206424T1 (de) 2001-10-15
AU7341598A (en) 1998-11-13
PL186894B1 (pl) 2004-03-31
EE03769B1 (et) 2002-06-17
WO1998047898A1 (fr) 1998-10-29
FR2762316B1 (fr) 1999-12-17
HUP0002456A2 (hu) 2000-12-28
IL132352A0 (en) 2001-03-19
RU2186066C2 (ru) 2002-07-27
SK283441B6 (sk) 2003-07-01
EE9900487A (et) 2000-06-15
NZ500396A (en) 2001-04-27
TR199902600T2 (xx) 2000-03-21
HUP0002456A3 (en) 2001-03-28
PL336315A1 (en) 2000-06-19
SK142699A3 (en) 2000-05-16
TW502005B (en) 2002-09-11
US6255319B1 (en) 2001-07-03
NO995040L (no) 1999-12-16
CO4750656A1 (es) 1999-03-31
CA2286106A1 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
US5929089A (en) 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for use as 5-Ht4 or H3 receptor ligands
JP2010514739A (ja) 置換オキシインドール誘導体及びバソプレッシン受容体リガンドとしてのその使用
CZ241994A3 (en) Derivatives of imidazol-4-ylpiperidine, process of their preparation and pharmaceutical compositions containing thereof
BG64053B1 (bg) Производни на 5-арил-3-(8-азабицикло(3.2.1)окт-3-ил)- 1,3,4-оксадиазол-2(3н)-он като лиганди на 5-нт долу 4 рецептори
NO178188B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4,5,6,7-tetrahydro-benzimidazolderivater
WO1999038864A1 (en) Oxazole derivatives as serotonin-1a receptor agonists
JPH06157518A (ja) 新規なオキサジアゾール誘導体又はその塩
MXPA99009506A (en) 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
US6248757B1 (en) 3-(Pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives and their use as 5-HT4 ligands
KR100474454B1 (ko) 5-ht₄또는h₃수용체리간드로서사용하기위한5-페닐-3-(피페리딘-4-일)-1,3,4-옥사디아졸-2(3h)-온유도체
JP2002504896A (ja) ５−フェニル−１，３，４−オキサジアゾール−２（３ｈ）−オン誘導体およびそれらの５−ｈｔ４リガンドとしての使用
FR2741070A1 (fr) Derives de 5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3h) -one, leur preparation et leur application en therapeutique
FR2763067A1 (fr) Derives de 3-(1-azabicyclo[2.2.2] oct-3-ylalkyl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique